Alpha Teknova, Inc. (NASDAQ:TKNO – Get Free Report) was the recipient of a large drop in short interest in August. As of August 31st, there was short interest totalling 268,900 shares, a drop of 19.4% from the August 15th total of 333,800 shares. Approximately 2.6% of the shares of the stock are short sold. Based on an average trading volume of 600,700 shares, the short-interest ratio is presently 0.4 days.
Analyst Ratings Changes
Separately, Stephens reissued an “overweight” rating and issued a $5.00 target price on shares of Alpha Teknova in a research note on Wednesday, July 10th.
Read Our Latest Analysis on Alpha Teknova
Insider Buying and Selling at Alpha Teknova
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the business. State Board of Administration of Florida Retirement System bought a new position in shares of Alpha Teknova during the first quarter valued at approximately $35,000. Redmile Group LLC increased its position in Alpha Teknova by 6.5% during the 1st quarter. Redmile Group LLC now owns 171,453 shares of the company’s stock valued at $434,000 after buying an additional 10,448 shares in the last quarter. FourWorld Capital Management LLC purchased a new position in Alpha Teknova during the first quarter valued at $135,000. Finally, Conestoga Capital Advisors LLC boosted its holdings in Alpha Teknova by 81.6% in the second quarter. Conestoga Capital Advisors LLC now owns 453,899 shares of the company’s stock worth $622,000 after acquiring an additional 203,950 shares in the last quarter. 13.81% of the stock is owned by hedge funds and other institutional investors.
Alpha Teknova Stock Performance
NASDAQ:TKNO opened at $4.40 on Tuesday. The company has a quick ratio of 3.28, a current ratio of 4.76 and a debt-to-equity ratio of 0.16. The firm’s fifty day simple moving average is $3.73 and its 200 day simple moving average is $2.64. The stock has a market cap of $179.62 million, a P/E ratio of -4.19 and a beta of 0.43. Alpha Teknova has a twelve month low of $1.15 and a twelve month high of $5.45.
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last released its earnings results on Tuesday, August 13th. The company reported ($0.13) EPS for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.03. The company had revenue of $9.61 million during the quarter, compared to analysts’ expectations of $9.50 million. Alpha Teknova had a negative return on equity of 37.00% and a negative net margin of 98.08%. During the same quarter last year, the business posted ($0.25) EPS. As a group, research analysts predict that Alpha Teknova will post -0.54 EPS for the current year.
About Alpha Teknova
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
See Also
- Five stocks we like better than Alpha Teknova
- Investing in Construction Stocks
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- How to Invest in Biotech Stocks
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- Dividend Capture Strategy: What You Need to Know
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.